Global Intravenous Immunoglobulin Market was estimated to be USD 8,820.44 Million in 2017 and is anticipated to reach USD 16,882.15 Million by 2026 growing at a CAGR of 7.6% due to increasing occurrence of lifestyle related disease including antibody deficiency disorders and obesity are the factors to drive the market growth.
read more..